Webinar: Unlocking Opportunities in China
Internationalization - Market Entry Strategies for Belgian HealthTech Companies
Why Biovia supports internationalization
One of Biovia's core missions is to support the growth and long-term sustainability of its members. For innovative healthtech companies, growth rarely stops at the Belgian border — and Biovia believes it shouldn't have to.
Belgian HealthTech companies, particularly start-ups and scale-ups, are developing solutions that have the potential to improve healthcare well beyond Europe. But ambition alone is not enough. Entering a new market, especially one as complex and fast-moving as China, requires access to the right knowledge, the right networks, and the right guidance at the right time.
That is exactly where Biovia steps in. As a spearhead cluster and ecosystem connector, Biovia actively works to open doors for its members, connecting them with international partners, facilitating access to new markets, and reducing the barriers that stand between a strong product and a global opportunity.
Internationalisation is not a bonus, it is a growth lever. A company that can scale beyond its home market becomes more resilient, more competitive, and ultimately more impactful. This event is for Biovia members only. |
China in particular represents one of the most significant market opportunities in global HealthTech. Its healthcare system is undergoing rapid transformation, its innovation ecosystem is maturing at pace, and demand for high-quality foreign solutions across digital health, medtech, is growing.
Background & Objectives
China's HealthTech sector is rapidly expanding across digital health, AI, biotechnology, and medical devices, creating strong opportunities for international companies seeking growth beyond Europe.
This webinar is designed specifically for Belgian HealthTech companies — particularly start-ups and scale-ups — who are exploring international expansion. The session provides practical insights into the Chinese market, including entry strategies, ecosystem support, and key operational considerations. By bringing together industry experts and companies with on-the-ground experience, the webinar aims to reduce market entry barriers and support informed decision-making.
Target Audience
- Belgian HealthTech start-ups and scale-ups
- Healthcare technology companies exploring international expansion
- Business development and strategy leads within HealthTech companies
Key Highlights
- Company-focused approach: tailored to the operational and strategic needs of HealthTech companies
- Greater Bay Area as entry point: a dynamic, innovation-driven region inspired by the Silicon Valley ecosystem
- Hong Kong as a bridge: lowering language and cultural barriers for international businesses
- Actionable insights: combining ecosystem overview with real company experiences
Proposed Program (1H30)
1. Opening & Introduction (2 min)
– Objectives and structure of the webinar
2. Overview of China's HealthTech Market (15 min)
– Speaker: Joshua Berlin, Head of Corporate Alliances & Business Development BioCentury
– Market size and growth trends
– Key opportunities for foreign companies
– Policy and innovation landscape
3. The Greater Bay Area & Role of Hong Kong (20 min)
– Speaker: Sabrina Chan, HKAPI
– Introduction to the Greater Bay Area (inspired by Silicon Valley ecosystem)
– Hong Kong as a strategic gateway for international companies
– Advantages: language accessibility, legal framework, capital concentration
– Key stakeholders and programs for foreign startups and enterprises
4. Accessing the Ecosystem: Partnerships & Funding (15 min)
– Speaker: Priscilla Chiu, Hong Kong Science and Technology Parks (HKSTP)
– How companies can connect with investors and partners in the region
– Soft-landing pathways and support programs for foreign startups
– Collaboration opportunities with local players
– Practical tips for building a presence
5. Legal & Regulatory Considerations (10 min)
– Speaker: Chris Cheng, Sidley Austin LLP (Life Science Practice)
– Company setup and market entry structures
– Regulatory landscape in healthcare
– IP protection and data compliance
6. Q&A and Closing (5 min)
Expected Outcome
- Better understanding of China's HealthTech market opportunities
- Clearer view on how to enter and navigate the ecosystem
- Initial connections with key stakeholders in Hong Kong and the Greater Bay Area
- Support for companies considering expansion into China
For more information, please contact us at info@biovia.be.